The effect of iodine compounds on patients with adenoviral keratoconjunctivitis.

The effect of iodine compounds on patients with adenoviral keratoconjunctivitis. - The effect of iodine on adenoviral keratoconjunctivitis.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000036821

Enrollment

Registered

2019-06-01

Start date

2017-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

adenoviral keratoconjunctivitis

Interventions

Topical iodine, 2 weeks. conventional treatment, topical antibiotics

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient with acute adenoviral keratoconjunctivitis.

Exclusion criteria

Exclusion criteria: The patient who has been treated elsewhere Pregnancy Presence of an ocular inflammation or infection other than adenoviral keratoconhunctivitis

Design outcomes

Primary

Measure	Time frame
The copy number of polymerase chain reaction copy number. Period of recovery.	—

Countries

Japan

Contacts

Public ContactKazuki Matsuura

Nojima Hospital Department of Ophthalmology

mastu224@ncn-k.net0858-22-6231

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026